A detailed history of Headlands Technologies LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Headlands Technologies LLC holds 287 shares of CORT stock, worth $13,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares
287
Previous 419 31.5%
Holding current value
$13,038
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$22.21 - $34.48 $2,931 - $4,551
-132 Reduced 31.5%
287 $9,000
Q1 2024

May 07, 2024

SELL
$21.1 - $27.46 $21,796 - $28,366
-1,033 Reduced 71.14%
419 $10,000
Q4 2023

Feb 02, 2024

BUY
$24.82 - $32.88 $36,038 - $47,741
1,452 New
1,452 $47,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.87B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.